{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-045341","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2026-10-01T19:50:43+00:00","discovered_at":"2026-10-01T19:52:00.306647+00:00","generated_at":"2026-10-12T14:20:48.738751+00:00","sec_items":["1.01","2.01","9.01","3.02","7.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Mangoceuticals' MangoRx IP sells 25% stake for $2.5M; $1.75M received, no MGRX shares issued","bullets":["Two accredited investors agreed to buy an aggregate 25% membership interest in subsidiary MangoRx IP Holdings for $2.5M; $1.75M (17.5% post-transaction) already received.","First investor paid $500,000 upfront in cash or Tether (USDT) plus $750,000 within 60 days; remaining 7.5% costs $750,000, due by November 28, 2026.","No MGRX common stock, warrants or other parent securities issued; CEO Jacob Cohen says the deal preserves the public capitalization structure.","MangoRx IP owns the MGX-0024 antiviral portfolio, led by U.S. Patent No. 11,517,523, with granted or pending patents in the EU, Canada, China, India, Australia and Japan.","Company cites Fortune Business Insights 2025 markets of ~$34.8B for global oral care and ~$39.8B for feed additives as potential applications."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-045341","json":"https://secwatch.observer/filing/0001493152-26-045341.json","markdown":"https://secwatch.observer/filing/0001493152-26-045341.md","text":"https://secwatch.observer/filing/0001493152-26-045341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315226045341/0001493152-26-045341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315226045341/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:20:48.738751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}